Date:26 March, 2016

Early Phase Clinical Trial

Would you consider taking part in an early phase Clinical Trial?

The Queen Elizabeth Hospital in Birmingham is running a phase I clinical trial to determine whether a new investigational drug could help to prevent liver damage by reducing the liver damaging Z-AAT protein. The trial is recruiting patients who have limited lung and liver disease and has 8 study visits over 3 months including a 2 night in-patient stay. Patients will be reimbursed for their time and travel expenses.

If you would like to hear more about the trial the please contact Anita Pye on telephone: 0121 371 3886

This study has been reviewed and approved by a research ethic committee. Ref#15/SS/0109
Version 1.0 dated 4Jan2016